World's Best Scientists 2026 revealed!
Sophie D. Fosså

Sophie D. Fosså

Award Badge
Medicine
Norway
2026

D-Index & Metrics

Medicine

D-Index
135
Citations
70511
World Ranking
2066
National Ranking
6

Research.com Recognitions

  • 2026 - Research.com Medicine in Norway Leader Award
  • 2025 - Research.com Medicine in Norway Leader Award
  • 2023 - Research.com Medicine in Norway Leader Award
  • 2022 - Research.com Medicine in Norway Leader Award

Overview

Sophie D. Fosså is affiliated with Oslo University Hospital in Norway. Their research spans several areas within Medicine, with a strong focus on oncology and cancer survivorship. They have contributed extensively to studies related to prostate cancer, childhood cancer survivors, and treatment-related effects among long-term cancer patients.

Their main fields of study include Medicine, with significant contributions in the subfields of Pulmonary and Respiratory Medicine, Surgery, Oncology, Pediatrics, Perinatology and Child Health, as well as Public Health, Environmental and Occupational Health.

Key topics in Sophie D. Fosså's work cover:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Childhood Cancer Survivors' Quality of Life
  • Cancer survivorship and care
  • Testicular diseases and treatments
  • Family Support in Illness
  • Bladder and Urothelial Cancer Treatments

The scientist has published in multiple respected venues, including:

  • Journal of Clinical Oncology
  • Scandinavian Journal of Urology
  • Acta Oncologica
  • Supportive Care in Cancer
  • European Urology Open Science

Frequent collaborators include Tor Åge Myklebust, Alv A. Dahl, Cecilie E. Kiserud, Paul C. Dinh, and Patrick O. Monahan.

Among recent publications are:

  • Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials (2023, The Lancet)
  • Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE) (2021, Human Reproduction)
  • Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy (2023, Journal of Clinical Oncology)
  • The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up (2020, European Heart Journal - Cardiovascular Imaging)
  • Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study) (2020, Supportive Care in Cancer)

Best Publications

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

    GM Mead;SP Stenning;P Cook;SD Fossa

  • Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

    Ragnhild A. Lothe;Paivi Peltomaki;Gunn Iren Meling;Lauri A. Aaltonen

  • Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

    Anders Widmark;Olbjørn Klepp;Arne Solberg;Jan Erik Damber

  • Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

    Lois B. Travis;Sophie D. Fosså;Sara J. Schonfeld;Mary L. McMaster

  • Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

    Cora N. Sternberg;P. H.M. De Mulder;J. H. Schornagel;C. Théodore

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

    Carsten Bokemeyer;Craig R. Nichols;Jean P. Droz;Hans J. Schmoll

  • Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.

    Hanne Stensheim;Bjørn Møller;Tini van Dijk;Sophie D. Fosså

  • Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

    C.N. Sternberg;P.H.M. de Mulder;J.H. Schornagel;C. Theodore

  • First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases

    Sten Nilsson;Roy H. Larsen;Roy H. Larsen;Sophie D. Fosså;Lise Balteskard

  • Test/Retest Study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire

    Marianne Jensen Hjermstad;Sophie D. Fossa;Kristin Bjordal;Stein Kaasa

  • An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    George van Andel;Andrew Bottomley;Sophie D. Fosså;Fabio Efficace

  • Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial

    Sophie D. Fossa;A. Horwich;J. M. Russell;J. T. Roberts

  • Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial

    A Ritchie;G Griffiths;M Parmar;SD Fossa

  • Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

    Hege S. Haugnes;Torgeir Wethal;Nina Aass;Olav Dahl

  • Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase

    E. K. Grov;A. A. Dahl;T. Moum;S. D. Fosså

  • Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

    David C. Hodgson;Ethel S. Gilbert;Graça M. Dores;Sara J. Schonfeld

Frequent Co-Authors

Alv A. Dahl
Alv A. Dahl University of Oslo
Roy M. Bremnes
Roy M. Bremnes University of Tromsø - The Arctic University of Norway
Lawrence H. Einhorn
Lawrence H. Einhorn Indiana University
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Ragnhild A. Lothe
Ragnhild A. Lothe University of Oslo
Howard D. Sesso
Howard D. Sesso Harvard Medical School
Hans H. Storm
Hans H. Storm Danish Cancer Society
Per Hall
Per Hall Karolinska Institute
Heikki Joensuu
Heikki Joensuu University of Helsinki
Robert Huddart
Robert Huddart Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to various educational routes beyond the traditional MD. Those interested in quickly entering healthcare may consider fast track lpn programs online, which prepare students to become Licensed Practical Nurses within a shorter timeframe.

For registered nurses aiming to advance their practice, bsn to np programs online offer a flexible path to becoming Nurse Practitioners in specialized fields like psychiatric mental health and more.

Not all medical careers involve direct patient care—some focus on managing systems and policies. Choosing an affordable healthcare administration degree online can equip you with essential leadership and operational skills for hospitals, clinics, or public health organizations.

Those ready to take on higher-level roles should explore affordable online mha programs, which provide comprehensive training in strategy and management tailored for modern healthcare environments.

Each of these pathways offers flexible, cost-effective options for building a rewarding career in the expanding field of healthcare.

Best Scientists Citing Sophie D. Fosså

Trending Scientists